An extra virgin olive oil rich diet intervention ameliorates the nonalcoholic steatohepatitis induced by a high-fat “Western-type” diet in mice

Molecular Nutrition and Food Research

Volumn 61, Issue 3, 2017, Pages

  Jurado Ruiz, Enrique ^a,b   Varela, Lourdes M ^a   Luque, Amparo ^a   Berná, Genoveva ^a,b   Cahuana, Gladys ^a,b   Martinez Force, Enrique ^c   Gallego Durán, Rocío ^d,e   Soria, Bernat ^a,b   de Roos, Baukje ^f   Romero Gómez, Manuel ^d,e   Martín, Franz ^a,b  

^a UNIVERSIDAD PABLO DE OLAVIDE   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c INSTITUTO DE LA GRASA   (Spain)

^d UNIVERSITY OF SEVILLE   (Spain)

^e INSTITUTO DE SALUD CARLOS III   (Spain)

^f ROWETT RESEARCH INSTITUTE   (United Kingdom)

Author keywords

Extra virgin olive oil (EVOO); High fat diet; Inflammation; Nonalcoholic fatty liver disease; Triolein

Indexed keywords

CALCIUM INDEPENDENT PHOSPHOLIPASE A2; CYTOKINE; OLIVE OIL; PNPLA3 PROTEIN, MOUSE;

ADIPOSE TISSUE; ANIMAL; BODY WEIGHT; C57BL MOUSE; DIET THERAPY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; LIPID DIET; LIPID METABOLISM; LIVER; MALE; METABOLISM; NONALCOHOLIC FATTY LIVER; ORGAN SIZE; PATHOLOGY; WESTERN DIET;

ADIPOSE TISSUE; ANIMALS; BODY WEIGHT; CYTOKINES; DIET, HIGH-FAT; DIET, WESTERN; GENE EXPRESSION REGULATION; LIPID METABOLISM; LIVER; MALE; MICE, INBRED C57BL; NON-ALCOHOLIC FATTY LIVER DISEASE; OLIVE OIL; ORGAN SIZE; PHOSPHOLIPASES A2, CALCIUM-INDEPENDENT;

EID: 85006816488     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201600549     Document Type: Article

References (37)

1. Charlton, M., Krishnan, A., Viker, K., Sanderson, S. et al., Fast food diet mouse: novel small animal model of Nash with ballooning, progressive fibrosis, and high physiological fidelity to the human condition. Am. J. Physiol. Gastrointest. Liver Physiol. 2011, 301, G825–G834.
2. Buzzetti, E., Pinzani, M., Tsochatzis, E. A., The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism 2016, 65, 1038–1048.
3. Wang, D., Wei, Y., Pagliassotti, M. J., Saturated fatty acids promote endoplasmic reticulum stress and liver injury in rats with hepatic steatosis. Endocrinology 2006, 147, 943–951.
4. Lamaziere, A., Richard, D., Bausero, P., Barbe, U. et al., Comparison of docosahexaenoic acid uptake in murine cardiomyocyte culture and tissue: significance to physiologically relevant studies. Prostaglandins Leukot. Essent. Fatty Acids 2015, 94, 49–54.
5. Soriguer, F., Morcillo, S., Cardona, F., Rojo-Martínez, G. et al., Pro12Ala polymorphism of the PPARG2 gene is associated with type 2 diabetes mellitus and peripheral insulin sensitivity in a population with a high intake of oleic acid. J. Nutr. 2006, 136, 2325–2330.
6. Sato, K., Arai, H., Mizuno, A., Fukaya, M. et al., Dietary palatinose and oleic acid ameliorate disorders of glucose and lipid metabolism in Zucker fatty rats. J. Nutr. 2007, 137, 1908–1915.
7. dos Santos, G. A., Ferreiras, M. A., de Oliveira, D. N., de Oliveira, V. et al., Identification of compounds from high-fat and extra virgin olive oil-supplemented diets in whole mouse liver extracts and isolated mitochondria using mass spectrometry. J. Mass Spectrom. 2015, 50, 951–958.
8. Valenzuela, R., Espinosa, A., Llanos, P., Hernandez-Rodas, M. C. et al., Anti-steatotic effects of an n-3 LCPUFA and extra virgin olive oil mixture in the liver of mice subjected to high-fat diet. Food Funct. 2016, 7, 140–150.
9. Ferramosca, A., Zara, V., Modulation of hepatic steatosis by dietary fatty acids. World J. Gastroenterol. 2014, 20, 1746–1755.
10. Martín-Peláez, S., Covas, M. I., Fitó, M., Kušar, A., Pravst, I., Health effects of olive oil polyphenols: recent advances and possibilities for the use of health claims. Mol. Nutr. Food Res. 2013, 57, 760–771.
11. Rincón-Cervera, M. A., Valenzuela, R., Hernandez-Rodas, M. C., Marambio, M. et al., Supplementation with antioxidant-rich extra virgin olive oil prevents hepatic oxidative stress and reduction of desaturation capacity in mice fed a high-fat diet: effects on fatty acid composition in liver and extrahepatic tissues. Nutrition 2016, 32, 1254–1267.
12. Giordano, E., Davalos, A., Visioli, F., Chronic hydroxytyrosol feeding modulates gluthatione-mediated oxido-reduction pathways in adipose tissue: a nutrigenomic study. Nutr. Metab. Cardiovasc. Dis. 2014, 24, 1144–1150.
13. Friedewald, W. T., Levy, R. I., Fredrickson, D. S., Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 1972, 18, 499–502.
14. Brunt, E. M., Kleiner, D. E., Wilson, L. A., Belt, P., Neuschwander-Tetri, B. A., Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings. Hepatology 2011, 53, 810–820.
15. Garcés, R., Mancha, M., One-step lipid extraction and fatty acid methyl esters preparation from fresh plant tissues. Anal. Biochem. 1993, 211, 139–143.
16. De Roos, B., Rungapamestry, V., Roos, K., Rucklidge, G. et al., Attenuation of inflammation and cellular stress-related pathways maintains insulin sensitivity in obese type 1 interleukin-1 receptor knockout mice on a high-fat diet. Proteomics 2009, 9, 3244–3256.
17. Yamaguchi, K., Nishimura, T., Ishiba, H., Seko, Y. et al., Blockade of interleukin 6 signalling ameliorates systemic insulin resistance through upregulation of glucose uptake in skeletal muscle and improves hepatic steatosis in high-fat diet fed mice. Liver Int. 2015, 35, 550–561.
18. Zigmond, E., Tayer-Shifman, O., Lalazar, G., Ben Ya'acov, A. et al., β-Glycosphingolipids ameliorated non-alcoholic steatohepatitis in the Psammomys obesus model. J. Inflamm. Res. 2014, 7, 151–158.
19. Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M. et al., Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 2003, 112, 1796–1808.
20. Nguyen, M. T., Favelyukis, S., Nguyen, A. K., Reichart, D. et al., A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via toll-like receptors 2 and 4 and JNK-dependent pathways. J. Biol. Chem. 2007, 282, 35279–35292.
21. Priore, P., Cavallo, A., Gnoni, A., Damiano, F. et al., Modulation of hepatic lipid metabolism by olive oil and its phenols in nonalcoholic fatty liver disease. IUBMB Life 2015, 67, 9–17.
22. Delgado, I., Carrasco, M., Cano, E., Carmona, R. et al., GATA4 loss in the septum transversum mesenchyme promotes liver fibrosis in mice. Hepatology 2014, 59, 2358–2370.
23. Ruiz-Gutiérrez, V., Pérez-Espinosa, A., Vázquez, C. M., Santa-María, C., Effects of dietary fats (fish, olive and high-oleic-acid sunflower oils) on lipid composition and antioxidant enzymes in rat liver. Br. J. Nutr. 1999, 82, 233–241.
24. Ronis, M. J., Baumgardner, J. N., Mareck,i, J. C., Hennings, L. et al., Dietary fat source alters hepatic gene expression profile and determines the type of liver pathology in rats overfed via total enteral nutrition. Physiol. Genomics 2012, 44, 1073–1089.
25. Wilson, C. G., Tran, J. L., Erion, D. M., Vera, N. B. et al., Hepatocyte-specific disruption of CD36 attenuates fatty liver and improves insulin sensitivity in HFD-fed mice. Endocrinology 2016, 157, 570–585.
26. Polson, D. A., Thompson, M. P., Macronutrient composition of the diet differentially affects leptin and adiponutrin mRNA expression in response to meal feeding. J. Nutr. Biochem. 2004, 15, 242–246.
27. Rotman, Y., Koh, C., Zmuda, J. M., Kleiner, D. E. et al., The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease. Hepatology 2010, 52, 894–903.
28. Smagris, E., BasuRay, S., Li, J., Huang, Y. et al., Pnpla3I148M knocking mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosis. Hepatology 2015, 61, 108–118.
29. Huang, Y., Cohen, J. C., Hobbs, H. H., Expression and characterization of a PNPLA3 protein isoform (I148M) associated with nonalcoholic fatty liver disease. J. Biol. Chem. 2011, 286, 37085–37093.
30. Giby, V. G., Ajith, T. A., Giby, V. G., Anan, T., Role of adipokines and peroxisome proliferator-activated receptors in nonalcoholic fatty liver disease. World J. Hepatol. 2014, 6, 570–579.
31. Abdelmegeed, M. A., Yoo, S.-H., Henderson, L. E., Gonzalez, F. J. et al., PPARalpha expression protects male mice from high fat-induced nonalcoholic fatty liver. J. Nutr. 2011, 141, 603–610.
32. Pirozzi, C., Lama, A., Simeoli, R., Paciello, O. et al., Hydroxytyrosol prevents metabolic impairment reducing hepatic inflammation and restoring duodenal integrity in a rat model of NAFLD. J. Nutr. Biochem. 2016, 30, 108–115.
33. Wang, X. W., Heegaard, N. H., Orum, H., Micro RNAs in liver disease. Gastroenterology 2012, 142, 1431–1443.
34. Altintas, E., Sezgin, O., S-adenosylhomocysteine hydrolase, S-adenosylmethionine, S-adenosylhomocysteine: correlations with ribavirin induced anemia. Med. Hypotheses 2004, 63, 834–837.
35. Murphy, S. K., Yang, H., Moylan, C. A., Pang, H. et al., Relationship between methylome and transcriptome in patients with nonalcoholic fatty liver disease. Gastroenterology 2013, 145, 1076–1087.
36. Komatsu, Y., Waku, T., Iwasaki, N., Ono, W. et al., Global analysis of DNA methylation in early-stage liver fibrosis. BMC Med. Genomics 2012, 5, 5, doi: 10.1186/1755-8794-5-5.
37. DiBello, P. M., Dayal, S., Kaveti, S., Zhang, D. et al., The nutrigenetics of hyperhomocysteinemia: quantitative proteomics reveals differences in the methionine cycle enzymes of gene-induced versus diet-induced hyperhomocysteinemia. Mol. Cell. Proteomics 2010, 9, 471–485.